• Exchange: NASDAQ GS
  • Sector: Health Care
  • Industry: Medical Equipment/Devices
  • Sub-Industry: Cardiovascular Devices

Thoratec Corp

+ Add to Watchlist


33.7500 USD 0.2600 0.78%

As of 20:10:00 ET on 07/11/2014.

Snapshot for Thoratec Corp (THOR)

Open: 33.4200 Day's Range: 33.1100 - 33.7500 Volume: 187,574
Previous Close: 33.4900 52wk Range: 30.0100 - 43.5800 1-Yr Rtn: +7.42%

Stock Chart for THOR

No chart data available.
  • THOR:US 33.7500
  • 1D
  • 1M
  • 1Y
Interactive THOR Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for THOR

Current P/E Ratio (ttm) 24.5800
Estimated P/E(12/2014) 19.1544
Relative P/E vs. SPX 1.3652
Earnings Per Share (USD) (ttm) 1.3731
Est. EPS (USD) (12/2014) 1.7620
Est. PEG Ratio 1.7280
Market Cap (M USD) 1,917.00
Shares Outstanding (M) 56.80
30 Day Average Volume 447,752
Price/Book (mrq) 2.8435
Price/Sale (ttm) 3.7776
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 07/23/2014
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for THOR

  • Revenue
  • Net Income (M/USD)
  • Profit Margin (%)

Company Profile & Key Executives for THOR

Thoratec Corporation researches, develops, manufactures, and markets medical devices for circulatory support and vascular graft applications. The Company's products include a ventricular assist device, an implantable left ventricular heart assist device, a vascular access graft, and a coronary artery bypass graft. Thoratec also supplies whole-blood coagulation testing equipment.

Gerhard F Burbach "Gary"President/CEODavid A LehmanSenior VP/Secy/Gen Cnsl
Taylor C HarrisVP/CFOVasant PadmanabhanVP:Technical Operations
More Company Profile & Key Executives for THOR

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Sponsored Links
sec ||= nil